Company overview
Ipca Laboratories Limited
CIN
L24239MH1949PLC007837
Name
Ipca Laboratories Limited
Entity type
Public
Paid up capital
₹253,704,218
Authorized capital
₹576,000,000
Industry name
Manufacturing (Metals and Chemicals, and products thereof)
Registry
ROC Mumbai
Status
Active
Incorporation date
19 October 1949
Address
48 Kandivli Industrialestate Kandivali (W), Mumbai, Maharashtra
Postal code
400067
Country
India
Primary goods traded
- 36.8% — Alcohol peroxides, ether peroxides, acetal and hemiacetal peroxides, ketone peroxides and their halogenated, sulphonated, nitrated or nitrosated derivatives (290960)
- 21.3% — Heterocyclic compounds (293329)
- 16.5% — Nitrile-function compounds (292690)
- 13.8% — Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters (292219)
- 11.6% — Acids (291719)
Directors
| Name | DIN | Designation | Join Date | Resign Date |
|---|---|---|---|---|
| Madhukar Ramchandra Chandurkar | 00012731 | Director | 31 October 1975 | 30 May 2014 |
| Ramakanta Panda | 01161791 | Director | 23 March 2013 | 7 March 2019 |
| Pranay Premchand Godha | 00016525 | Wholetime Director | 11 November 2008 | |
| Kamal Kishore Seth | 00194986 | Director | 29 March 2019 | |
| Dev Parkash Hemraj Yadava | 00778976 | 13 April 2012 | ||
| Prashant Premchand Godha | 00012759 | Wholetime Director | 28 July 2011 | |
| Premchand Gigalal Godha | 00012691 | Managing Director | 31 January 2012 | |
| Anand Trimbak Kusre | 00818477 | Director | 21 January 2010 | |
| Ramachandran Thembalath Moothedath Ramankutty Nair | 00022545 | Director | 21 August 1994 | 31 October 2008 |
| Ajit Kumar Jain | 00012657 | Managing Director | 21 August 2009 | |
| Manisha Premnath | 05280048 | Director | 21 September 2014 |
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Tatarasa Primatama | buyer | $8,634,599 | 5.88% |
| Catholic Relief Services - Uscc | buyer | $2,191,851 | 1.49% |
| BASF Hong Kong Limited | seller | $1,708,864 | 1.16% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 29 January 2023 | RU | 3004900002 | Medicines Packed In Forms Or Packaging For Retail Sale, Is Not A Vital Plant, Not For Veterinary Section, Does Not Contain Ethyl Alcohol, Nemozol (Albendazole), Film-Coated Tablets 400 Mg, (Blister) 1 X Cards | Hinkus Pharmacies Llc | RU | Ipca Laboratories Limited | $1,129,670.00 | |
| 30 January 2023 | RU | 3004900002 | Medicinal Products Packed In Forms Or Packaging For Retail Sale, Is Not A Vital Plant, Not For Veterinary, Does Not Contain Ethyl Alcohol, Nemozol (Albendazole), Film-Coated Tablets 400 Mg, (Blister) 5 X Cards | Hinkus Pharmacies Llc | RU | Ipca Laboratories Limited | $1,070,140.00 | |
| 23 December 2022 | RU | 3004900002 | Medicines Packed In Forms Or Packaging For Retail Sale, Is Not A Vital Plant, Not For Veterinary, Does Not Contain Ethyl Alcohol, Nemozol (Albendazole), Film-Coated Tablets 400 Mg, (Blister) 5 X Cards | Hinkus Pharmacies Llc | RU | Ipca Laboratories Limited | $1,061,790.00 | |
| 5 February 2019 | IN | 29096000 | Artemisinin - | Ipca Laboratories Limited | IN | $1,025,000.00 | ||
| 19 November 2018 | IN | 29096000 | Artemisinin | Ipca Laboratories Limited | IN | Jiangsu Gtig Hua Tai Company Limited | $975,000.00 | |
| 13 December 2019 | RU | 3004900002 | Medicines Prepared In Form Or Packaging For Retails Are Not Vital And Essential Drugs, Not For Veterinary Medicines, Does Not Contain Ethyl Alcohol, Nemozol (Albendazole) Tablets Pok | Hinkus Pharmacies Llc | RU | Ipca Laboratories Limited | $859,012.72 | |
| 23 June 2022 | IN | 29096000 | Artemisinin | Ipca Laboratories Limited | IN | Guangxi Xiancaotang Pharmaceutical Company Limited | $786,000.00 | |
| 14 April 2022 | IN | 29096000 | Artemisinin | Ipca Laboratories Limited | IN | Hunan Vigor Bio Tech Company Limited | $780,000.00 | |
| 11 July 2022 | IN | 29096000 | Artemisinin | Ipca Laboratories Limited | IN | Guangxi Xiancaotang Pharmaceutical Company Limited | $776,654.56 | |
| 1 March 2022 | IN | 29332990 | (Re-Import After Rejected) Losartan Potassium Usp (The Material Is Returned To Comply With The Recent Notification On Az | Ipca Laboratories Limited | IN | Sanofi Aventis De Colombia Sa | $769,931.93 |
0 of 20 row(s) selected.